Zhang Tianyi, Yang Li, Zhai Yunyan, Feng Li, Zhou Tao, Wang Xumei
School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, China.
Plant J. 2025 Aug;123(4):e70417. doi: 10.1111/tpj.70417.
The quality of traditional Chinese medicine (TCM) greatly relies on the accumulation of medicinal compounds. As a crucial TCM, rhubarb (dahuang) exhibits significant quality variations across different geographical production regions. However, the insufficient knowledge on metabolic diversity and metabolic pathways of specialized metabolites across distinct geographical regions fundamentally constrains our ability to decipher the mechanisms driving quality differences among different production areas in rhubarb. Here, we infer the evolutionary mechanisms underlying metabolomic diversity of the rhubarb source plants (Rheum palmatum complex) using population transcriptomic and metabolomic analyses. Our findings revealed that there were three distinct lineages within the complex. The divergence of eastern and western lineages could be dated back to ~2.31 million years ago (Mya), while the split between NW and SW lineages in western China occurred ~1.64 Mya. Gene expression analysis revealed comparable distribution proportions of highly expressed and lowly expressed genes among populations, while divergence in expression diversity was observed between specific lineages. Untargeted metabolomic analyses detected 819 differentially accumulated metabolites in different genetic lineages. Subsequent analysis uncovered potential associations between genetic variants and the accumulation of medicinal compounds. Notably, four PKSs, among which RpALSs were included, demonstrated a high degree of connectivity with other genes involved in anthraquinone and stilbene biosynthesis. Additionally, we found that one UGT was involved in the biosynthesis of sennoside A through mGWAS. Our results provide valuable insights into the quality variation of rhubarb and establish a solid foundation for future research and development endeavors.
中药的质量很大程度上依赖于药用化合物的积累。作为一种重要的中药,大黄在不同地理产区表现出显著的质量差异。然而,对于不同地理区域中特殊代谢产物的代谢多样性和代谢途径的认识不足,从根本上限制了我们解读大黄不同产区质量差异驱动机制的能力。在此,我们通过群体转录组学和代谢组学分析推断大黄源植物(掌叶大黄复合体)代谢组多样性的进化机制。我们的研究结果表明,该复合体中有三个不同的谱系。东部和西部谱系的分化可追溯到约231万年前,而中国西部西北和西南谱系之间的分裂发生在约164万年前。基因表达分析显示,高表达和低表达基因在群体中的分布比例相当,但在特定谱系之间观察到表达多样性的差异。非靶向代谢组学分析在不同遗传谱系中检测到819种差异积累的代谢产物。随后的分析揭示了基因变异与药用化合物积累之间的潜在关联。值得注意的是,四个聚酮合酶(PKSs),其中包括RpALSs,与参与蒽醌和芪生物合成的其他基因表现出高度的关联性。此外,我们通过多基因关联研究(mGWAS)发现一个尿苷二磷酸葡萄糖基转移酶(UGT)参与了番泻苷A的生物合成。我们的结果为大黄的质量变异提供了有价值的见解,并为未来的研发工作奠定了坚实的基础。